Management of postdischarge nausea and vomiting after ambulatory surgery

Current Opinion in Anaesthesiology

Volumn 24, Issue 6, 2011, Pages 612-619

  Melton, M Stephen ^a   Klein, Stephen M ^a   Gan, Tong J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

ambulatory surgery; postdischarge nausea and vomiting; postoperative nausea and vomiting

Indexed keywords

ANTIEMETIC AGENT; APREPITANT; CASOPITANT; CORTICOSTEROID; DEXAMETHASONE; DROPERIDOL; FOSAPREPITANT; GLUCOSE; GRANISETRON; NEUROKININ 1 RECEPTOR ANTAGONIST; ONDANSETRON; PALONOSETRON; PROMETHAZINE; ROLAPITANT; SCOPOLAMINE; SEROTONIN 3 RECEPTOR;

ADRENAL SUPPRESSION; AMBULATORY SURGERY; BINDING AFFINITY; CONFUSION; CORTICOSTEROID THERAPY; DEPRESSION; DRUG BRAIN LEVEL; DRUG EFFICACY; DRUG HALF LIFE; DRUG INDUCED HEADACHE; DRUG RECEPTOR BINDING; DRUG RESPONSE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GLUCOSE BLOOD LEVEL; HEADACHE; HOSPITAL DISCHARGE; HUMAN; INFECTION; INSOMNIA; MONOTHERAPY; OPTIMAL DRUG DOSE; POSTOPERATIVE CARE; POSTOPERATIVE NAUSEA AND VOMITING; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SIDE EFFECT; SIGNAL TRANSDUCTION; SKIN IRRITATION; SOMNOLENCE; SURGICAL INFECTION; URINE RETENTION; VISUAL DISORDER; WOUND HEALING IMPAIRMENT; XEROSTOMIA;

AMBULATORY SURGICAL PROCEDURES; ANESTHESIA; ANTIEMETICS; CHOLINERGIC ANTAGONISTS; COMBINED MODALITY THERAPY; DEXAMETHASONE; GLUCOCORTICOIDS; HUMANS; ISOQUINOLINES; PATIENT DISCHARGE; POSTOPERATIVE NAUSEA AND VOMITING; QUINUCLIDINES; RECEPTORS, NEUROKININ-1; RISK FACTORS; SEROTONIN ANTAGONISTS;

EID: 81855163406     PISSN: 09527907     EISSN: 14736500     Source Type: Journal    
DOI: 10.1097/ACO.0b013e32834b9468     Document Type: Review

References (78)

1. Cohen MM, Duncan PG, De Boer DP, Tweed WA. The postoperative interview: assessing risk factors for nausea and vomiting. Anesth Analg 1994; 78:7-16. (Pubitemid 24012595)
2. Palazzo MG, Strunin L. Anaesthesia and emesis. I: etiology. Can J Anaesth 1984; 31:178-187. (Pubitemid 14167989)
3. Kovac AL. Prevention and treatment of postoperative nausea and vomiting. Drugs 2000; 59:213-243. (Pubitemid 30168508)
4. Hill RP, Lubarsky DA, Phillips-Bute B, et al. Cost-effectiveness of prophylactic antiemetic therapy with ondansetron, droperidol, or placebo. Anesthesiology 2000; 92:958-967. (Pubitemid 30180971)
5. Watcha MF. The cost-effective management of postoperative nausea and vomiting. Anesthesiology 2000; 92:931-933. (Pubitemid 30180966)
6. Gan T, Sloan F, Dear Gde L, et al. How much are patients willing to pay to avoid postoperative nausea and vomiting? Anesth Analg 2001; 92:393-400. (Pubitemid 32127625)
7. White PF, Watcha MF. Postoperative nausea and vomiting: prophylaxis versustreatment. Anesth Analg 1999; 89:1337-1339.
8. Gan TJ, Meyer TA, Apfel CC, et al. Society for ambulatory anesthesia guidelines for the management of postoperative nausea and vomiting. Anesth Analg 2007; 105:1615-1628;tableofcontents. . (Pubitemid 350190555)
9. Apfel CC, Korttila K, Abdalla M, et al. A factorial trial of six interventions for the prevention of postoperative nausea and vomiting. N Engl J Med 2004; 350:2441-2451.
10. White PF, Sacan O, Nuangchamnong N, et al. The relationship between patient risk factors and early versus late postoperative emetic symptoms. Anesth Analg 2008; 107:459-463.
11. Carroll NV, Miederhoff P, Cox FM, Hirsch JD. Postoperative nausea and vomiting after discharge from outpatient surgery centers. Anesth Analg 1995; 80:903-909.
12. Gupta A, Wu CL, Elkassabany N, et al. Does the routine prophylactic use of antiemetics affect the incidence of postdischarge nausea and vomiting following ambulatory surgery?: A systematic review of randomized controlled trials. Anesthesiology 2003; 99:488-495. (Pubitemid 36909577)
13. Wu CL, Berenholtz SM, Pronovost PJ, Fleisher LA. Systematic review and analysis of postdischarge symptoms after outpatient surgery. Anesthesiology 2002; 96:994-1003. (Pubitemid 34266696)
14. Cullen KA, Hall MJ, Golosinskiy A. Ambulatory surgery in the United States, 2006. National Health Statistics Reports 2009. pp. 1-25.
15. Wang SC, Borison HL. The vomiting center: a critical experimental analysis. Arch Neurol Psychiatry 1950; 63:928-941.
16. Watcha MF, White PF. Postoperative nausea and vomiting: its etiology, treatment, and prevention. Anesthesiology 1992; 77:162-184.
17. Borison HL. Area postrema: chemoreceptor circumventricular organ of the medulla oblongata. Prog Neurobiol 1989; 32:351-390.
18. Le TP, Gan TJ. Update on the management of postoperative nausea and vomiting and postdischarge nausea and vomiting in ambulatory surgery. Anesthesiol Clin 2010; 28:225-249.
19. Gan TJ. Mechanisms underlying postoperative nausea and vomiting and neurotransmitter receptor antagonist-based pharmacotherapy. CNS Drugs 2007; 21:813-833. (Pubitemid 47443303)
20. Rueffert H, Thieme V, Wallenborn J, et al. Do variations in the 5-HT3A and 5-HT3B serotonin receptor genes (HTR3A and HTR3B) influence the occurrence of postoperative vomiting? Anesth Analg 2009; 109:1442-1447.
21. Kolodzie K, Apfel CC. Nausea and vomiting after office-based anesthesia. Curr Opin Anaesthesiol 2009; 22:532-538.
22. Apfel CC, Laara E, Koivuranta M, et al. A simplified risk score for predicting postoperative nausea and vomiting: conclusions from cross-validations between two centers. Anesthesiology 1999; 91:693-700. (Pubitemid 29418651)
23. Sinclair DR, Chung F, Mezei G. Can postoperative nausea and vomiting be predicted? Anesthesiology 1999; 91:109-118. (Pubitemid 29307343)
24. Mattila K, Toivonen J, Janhunen L, et al. Postdischarge symptoms after ambulatory surgery: first-week incidence, intensity, and risk factors. Anesth Analg 2005; 101:1643-1650. (Pubitemid 41720614)
25. Apfel CC, Philip B, Stader A, et al. , editors. A prediction model for post-discharge nausea and vomiting after ambulatory surgery. Proceedings of the 2009 Annual Meeting of the American Society of Anesthesiologists; 2009.
26. Chinnappa V, Chung F. Postdischarge nausea and vomiting: an over-looked aspect of ambulatory anesthesia? Can J Anaesth 2008; 55:565-571.
27. Andrews PL Physiologyofnauseaand vomiting. Br J Anaesth 1992; 69:2S-19S.
28. Miller AD, Leslie RA. The area postrema and vomiting. Front Neuroendocrinol 1994; 15:301-320.
29. Wong EH, Clark R, Leung E, et al. The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitro. Br J Pharmacol V 114 1995; 851-859.
30. Ho KY, Gan TJ. Pharmacology, pharmacogenetics, and clinical efficacy of 5-hydroxytryptamine type 3 receptor antagonists for postoperative nausea and vomiting. Curr Opin Anaesthesiol 2006; 19:606-611. (Pubitemid 44722007)
31. Kovac AL, Eberhart L, Kotarski J, et al. A randomized, double-blind study to evaluate the efficacy and safety of three different doses of palonosetron versus placebo in preventing postoperative nausea and vomiting over a 72-hour period. Anesth Analg 2008; 107:439-444.
32. Candiotti KA, Kovac AL, Melson TI, et al. A randomized, double-blind study to evaluate the efficacy and safety of three different doses of palonosetron versus placebo for preventing postoperative nausea and vomiting. Anesth Analg 2008; 107:445-451.
33. Park SK, Cho EJ, Randomized A. Double-blind trial of palonosetron compared with ondansetron in preventing postoperative nausea and vomiting after gynaecological laparoscopic surgery. J Int Med Res 2011; 39:399-407.
34. Bajwa SS, Bajwa SK, Kaur J, et al. Palonosetron: a novel approach to control postoperative nausea and vomiting in day care surgery. Saudi J Anaesth 2011; 5:19-24.
35. Bhattacharjee DP, Dawn S, Nayak S, et al. A comparative study between palonosetron and granisetron to prevent postoperative nausea and vomiting after laparoscopic cholecystectomy. J Anaesthesiol Clin Pharmacol 2010; 26:480-483.
36. Blitz JD, Haile M, Kline R, et al. A randomized double blind study to evaluate efficacy of palonosetron with dexamethasone versus palonosetron alone for prevention of postoperative and postdischarge nausea and vomiting in subjects undergoing laparoscopic surgeries with high emetogenic risk. Am J Ther 2011. [Epub ahead of print]
37. White PF, Tang J, Hamza MA, et al. The use of oral granisetron versus intravenous ondansetron for antiemetic prophylaxis in patients undergoing laparoscopic surgery: the effect on emetic symptoms and quality of recovery. Anesth Analg 2006; 102:1387-1393.
38. Gan TJ, Candiotti KA, Klein SM, et al. Double-blind comparison ofgranisetron, promethazine, or a combination of both for the prevention of postoperative nausea and vomiting in females undergoing outpatient laparoscopies. Can J Anaesth 2009; 56:829-836.
39. Gan TJ, Franiak R, Reeves J. Ondansetron orally disintegrating tablet versus placebo for the prevention of postdischarge nausea and vomiting after ambulatorysurgery. Anesth Analg 2002; 94:1199-1200. (Pubitemid 34441835)
40. Pan PH, Lee SC, Harris LC. Antiemetic prophylaxis for postdischarge nausea and vomiting and impact on functional quality of living during recovery in patients with high emetic risks: a prospective, randomized, double-blind comparison of two prophylactic antiemetic regimens. Anesth Analg 2008; 107:429-438.
41. Henzi I, Walder B, Tramer MR. Dexamethasone for the prevention of post-operative nausea and vomiting: a quantitative systematic review. Anesth Analg 2000; 90:186-286.
42. Wattwil M, Thorn SE, Lovqvist A, et al. Dexamethasone is as effec-tive as ondansetron for the prevention of postoperative nausea and vomiting following breast surgery. Acta Anaesthesiol Scand 2003; 47: 823-827. (Pubitemid 36898029)
43. De Oliveira GS Jr, Ahmad S, Fitzgerald PC, et al. Dose ranging study on the effect of preoperative dexamethasone on postoperative quality of recovery and opioid consumption after ambulatory gynaecological surgery. Br J Anaesth 2011; 107:362-371.
44. Murphy GS, Szokol JW, Greenberg SB, et al. Preoperative dexamethasone enhancesqualityofrecoveryafterlaparoscopic cholecystectomy: effecton in-hospital and postdischarge recovery outcomes. Anesthesiology 2011; 114:882-890.
45. Feroci F, Rettori M, Borrelli A, et al. Dexamethasone prophylaxis before thyroidectomy to reduce postoperative nausea, pain, and vocal dysfunction: a randomized clinical controlled trial. Head Neck 2011; 33:840-846.
46. Murphy GS, Sherwani SS, Szokol JW, et al. Small-dose dexamethasone improves quality of recovery scores after elective cardiac surgery: a rando-mized, double-blind, placebo-controlled study. J Cardiothorac Vasc Anesth 2011. [Epub ahead of print]
47. White PF, Tang J, Song D, et al. Transdermal scopolamine: an alternative to ondansetron and droperidol for the prevention of postoperative and post-discharge emetic symptoms. Anesth Analg 2007; 104:92-96. (Pubitemid 46360427)
48. Eberhart LH, Graf J, Morin AM, et al. Randomised controlled trial of the effect of oral premedication with dexamethasone on hyperglycaemic response to abdominal hysterectomy. Eur J Anaesthesiol 2011; 28:195-201.
49. Chrousos GP, Kino T. Glucocorticoid action networks and complex psychia-tric and/orsomatic disorders. Stress 2007; 10:213-219. (Pubitemid 46789478)
50. Coloma M, Duffy LL, White PF, et al. Dexamethasone facilitates discharge after outpatient anorectal surgery. Anesth Analg 2001; 92:85-88. (Pubitemid 32039183)
51. Wu JI, Lu SF, Chia YY, et al. Sevoflurane with or without antiemetic prophy-laxis of dexamethasone in spontaneously breathing patients undergoing outpatient anorectal surgery. J Clin Anesth 2009; 21:469-473.
52. Thomas S, Beevi S. Dexamethasone reduces the severity of postoperative sore throat. Can J Anaesth 2007; 54:897-901. (Pubitemid 350206607)
53. Kranke P, Morin AM, Roewer N, et al. The efficacy and safety of transdermal scopolamine for the prevention of postoperative nausea and vomiting: a quantitative systematic review. Anesth Analg 2002; 95:133-143; table of contents. (Pubitemid 34705567)
54. Bailey PL, Streisand JB, Pace NL, et al. Transdermal scopolamine reduces nausea and vomiting after outpatient laparoscopy. Anesthesiology 1990; 72:977-980. (Pubitemid 20204653)
55. Apfel CC, Zhang K, George E, et al. Transdermal scopolamine for the prevention of postoperative nausea and vomiting: a systematic review and meta-analysis. Clin Ther 2010; 32:1987-2002.
56. Sah N, Ramesh V, Kaul B, et al. Transdermal scopolamine patch in addition to ondansetron for postoperative nausea and vomiting prophylaxis in patients undergoing ambulatory cosmetic surgery. J Clin Anesth 2009; 21:249-252.
57. Gan TJ, Sinha AC, Kovac AL, et al. A randomized, double-blind, multicenter trial comparing transdermal scopolamine plus ondansetron to ondansetron alone for the prevention of postoperative nausea and vomiting in the out-patient setting. Anesth Analg 2009; 108:1498-1504.
58. Colin I, Blondeau C, Baude A. Neurokinin release in the rat nucleus of the solitary tract via NMDA and AMPA receptors. Neuroscience 2002; 115:1023-1033. (Pubitemid 35351694)
59. Minthorn E, Mencken T, King AG, et al. Pharmacokinetics and brain penetration of casopitant, a potent and selective neurokinin-1 receptor antagonist, in the ferret. Drug Metab Dispos 2008; 36:1846-1852.
60. Diemunsch P, Gan TJ, Philip BK, et al. Single-doseaprepitantvsondansetron for the prevention of postoperative nausea and vomiting: a randomized, double-blind phase III trial in patients undergoing open abdominal surgery. Br J Anaesth 2007; 99:202-211. (Pubitemid 47260214)
61. Gan TJ, Apfel CC, Kovac A, et al. A randomized, double-blind comparison of the NK1 antagonist, aprepitant, versus ondansetron for the prevention of postoperative nausea and vomiting. Anesth Analg 2007; 104:1082-1089; tables of contents. . (Pubitemid 46649925)
62. Hartrick CT,Tang YS, Hunstad D, et al. Aprepitantvs. multimodal prophylaxis in the prevention of nausea and vomiting following extended-release epidural morphine. Pain Pract 2010; 10:245-248.
63. Habib AS, Keifer JC, Borel CO, et al. A comparison of the combination of aprepitant and dexamethasone versus the combination of ondansetron and dexamethasone for the prevention of postoperative nausea and vomiting in patients undergoing craniotomy. Anesth Analg 2011; 112: 813-818.
64. Singla NK, Singla SK, Chung F, et al. Phase II studyto evaluate the safetyand efficacy of theoral neurokinin-1 receptorantagonistcasopitant (GW679769) administered with ondansetron forthe prevention of postoperative and post-discharge nausea and vomiting in high-risk patients. Anesthesiology 2010; 113:74-82.
65. Altorjay A, Melson T, Chinachoit T, et al. Casopitant and ondansetron for postoperative nausea and vomiting prevention in women at high risk for emesis: a phase 3 study. Arch Surg 2011; 146:201-206.
66. Gan TJ, Gu J, Singla N, et al. Rolapitant for the prevention of postoperative nausea and vomiting: a prospective, double-blinded, placebo-controlled randomizedtrial. Anesth Analg 2011; 112:804-812.
67. Tang J, Wang B, White PF, et al. The effect of timing of ondansetron administration on its efficacy, cost-effectiveness, and cost-benefit as a pro-phylactic antiemetic in the ambulatory setting. Anesth Analg 1998; 86:274-282. (Pubitemid 28079475)
68. Roberts GW, Bekker TB, Carlsen HH, et al. Postoperative nausea and vomiting are strongly influenced by postoperative opioid use in a dose-related manner. Anesth Analg 2005; 101:1343-1348. (Pubitemid 41531869)
69. White PF, Kehlet H. Improving postoperative pain management: what are the unresolved issues? Anesthesiology 2010; 112:220-225.
70. Richman JM, Liu SS, Courpas G, et al. Does continuous peripheral nerve block provide superior pain control to opioids? A meta-analysis. Anesth Analg 2006; 102:248-257. (Pubitemid 43038316)
71. Klein SM, Evans H, Nielsen KC, et al. Peripheral nerve block techniques for ambulatorysurgery. Anesth Analg 2005; 101:1663-1676. (Pubitemid 41720618)
72. Klein SM, Nielsen KC. Brachial plexus blocks: infusions and other mechanisms to provide prolonged analgesia. Curr Opin Anaesthesiol 2003; 16:393-399. (Pubitemid 36951893)
73. Klein SM, Nielsen KC,Greengrass RA, et al. Ambulatorydischargeafter long-acting peripheral nerve blockade: 2382 blocks with ropivacaine. Anesth Analg 2002; 94:65-70; table of contents. . (Pubitemid 34038720)
74. Jankowski CJ, Weingarten TN, Martin DP, et al. Randomised trial of intranasal nicotine and postoperative pain, nausea and vomiting in nonsmoking women. Eur J Anaesthesiol 2011.
75. White PF, Issioui T, Hu J, et al. Comparative efficacy of acustimulation (Relief Band) versus ondansetron (Zofran) in combination with droperidol for preventing nausea and vomiting. Anesthesiology 2002; 97:1075-1081. (Pubitemid 35265558)
76. Scuderi PE, James RL, Harris L, Mims GR 3rd. Multimodal antiemetic management prevents early postoperative vomiting after outpatient laparo-scopy. Anesth Analg 2000; 91:1408-1414.
77. Habib AS, White WD, Eubanks S, et al. A randomized comparison of a multimodal management strategy versus combination antiemetics for the prevention of postoperative nausea and vomiting. Anesth Analg 2004; 99:77-81. (Pubitemid 38808168)
78. Yogendran S, Asokumar B, Cheng DC, Chung F. A prospective randomized double-blinded study of the effect of intravenous fluid therapy on adverse outcomes on outpatient surgery. Anesth Analg 1995; 80:682-686.